Literature DB >> 27808265

Unruptured intracranial aneurysms: development, rupture and preventive management.

Nima Etminan1, Gabriel J Rinkel2.   

Abstract

Saccular unruptured intracranial aneurysms (UIAs) have a prevalence of 3% in the adult population, and are being increasingly detected because of improved quality and higher frequency of cranial imaging. Large amounts of data, providing varying levels of evidence, have been published on aneurysm development, progression and rupture, but less information is available on the risks and efficacy of preventive treatment. When deciding how to best manage UIAs, clinicians must consider the age and life expectancy of the patient, the estimated risk of rupture, the risk of complications attributed to preventive treatment, and the level of anxiety caused by the awareness of having an aneurysm. This Review highlights the latest human data on the formation, progression and rupture of intracranial aneurysms, as well as risks associated with preventive treatment. Considering these we discuss the implication for clinical management. Furthermore, we highlight pivotal questions arising from current data on intracranial aneurysms and the implications the data have for future experimental or clinical research. We also discuss data on novel radiological surrogates for rupture for those aneurysms that do not require preventive occlusion. Finally, we provide guidance for clinicians who are confronted with patients with incidentally detected UIAs.

Entities:  

Mesh:

Year:  2016        PMID: 27808265     DOI: 10.1038/nrneurol.2016.150

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  119 in total

1.  Clinical, radiological, and flow-related risk factors for growth of untreated, unruptured intracranial aneurysms.

Authors:  A Stijntje E Bor; Andreas T Tiel Groenestege; Karel G terBrugge; Ronit Agid; Birgitta K Velthuis; Gabriel J E Rinkel; Marieke J H Wermer
Journal:  Stroke       Date:  2014-11-13       Impact factor: 7.914

2.  Uncertainty and agreement in the management of unruptured intracranial aneurysms.

Authors:  Tim E Darsaut; Laurent Estrade; Sara Jamali; Michel W Bojanowski; Miguel Chagnon; Jean Raymond
Journal:  J Neurosurg       Date:  2014-01-03       Impact factor: 5.115

3.  Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms.

Authors:  M J H Wermer; I C van der Schaaf; B K Velthuis; A Algra; E Buskens; G J E Rinkel
Journal:  Brain       Date:  2005-07-06       Impact factor: 13.501

4.  Size ratio can highly predict rupture risk in intracranial small (<5 mm) aneurysms.

Authors:  Daina Kashiwazaki; Satoshi Kuroda
Journal:  Stroke       Date:  2013-06-06       Impact factor: 7.914

5.  Configuration of intracranial arteries and development of aneurysms: a follow-up study.

Authors:  A Stijntje E Bor; Birgitta K Velthuis; Charles B Majoie; Gabriel J E Rinkel
Journal:  Neurology       Date:  2008-02-26       Impact factor: 9.910

6.  Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection.

Authors:  Robert D Brown; John Huston; Richard Hornung; Tatiana Foroud; David F Kallmes; Dawn Kleindorfer; Irene Meissner; Daniel Woo; Laura Sauerbeck; Joseph Broderick
Journal:  J Neurosurg       Date:  2008-06       Impact factor: 5.115

7.  Recurrent subarachnoid hemorrhage caused by a de novo basilar tip aneurysm developing within 8 weeks after clipping of a ruptured anterior communicating artery aneurysm: case report.

Authors:  Karl-Michael Schebesch; Christian Doenitz; Roland Zoephel; Thomas Finkenzeller; Alexander T Brawanski
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

8.  A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials.

Authors:  Jean Raymond; Tim E Darsaut; Andrew J Molyneux
Journal:  Trials       Date:  2011-03-04       Impact factor: 2.279

9.  Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall.

Authors:  Juhana Frösen; Riikka Tulamo; Tommi Heikura; Sini Sammalkorpi; Mika Niemelä; Juha Hernesniemi; Anna-Liisa Levonen; Sohvi Hörkkö; Seppo Ylä-Herttuala
Journal:  Acta Neuropathol Commun       Date:  2013-10-28       Impact factor: 7.801

10.  Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results.

Authors:  David M Hasan; Nohra Chalouhi; Pascal Jabbour; Aaron S Dumont; David K Kung; Vincent A Magnotta; William L Young; Tomoki Hashimoto; H Richard Winn; Donald Heistad
Journal:  J Am Heart Assoc       Date:  2013-02-22       Impact factor: 5.501

View more
  92 in total

Review 1.  Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms.

Authors:  Juhana Frösen; Juan Cebral; Anne M Robertson; Tomohiro Aoki
Journal:  Neurosurg Focus       Date:  2019-07-01       Impact factor: 4.047

2.  Unruptured intracranial aneurysms: development, rupture and preventive management.

Authors:  Nima Etminan; Gabriel J Rinkel
Journal:  Nat Rev Neurol       Date:  2017-02-01       Impact factor: 42.937

3.  Differences in Cerebral Aneurysm Rupture Rate According to Arterial Anatomies Depend on the Hemodynamic Environment.

Authors:  S Fukuda; Y Shimogonya; N Yonemoto
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-11       Impact factor: 3.825

4.  Management of unruptured intracranial aneurysms: correlation of UIATS, ELAPSS, and PHASES with referral center practice.

Authors:  James Feghali; Abhishek Gami; Justin M Caplan; Rafael J Tamargo; Cameron G McDougall; Judy Huang
Journal:  Neurosurg Rev       Date:  2020-07-22       Impact factor: 3.042

5.  Unruptured Intracranial Aneurysms- Pathogenesis and Individualized Management.

Authors:  Nima Etminan; Arnd Dörfler; Helmuth Steinmetz
Journal:  Dtsch Arztebl Int       Date:  2020-04-03       Impact factor: 5.594

6.  Intracranial aneurysms at higher clinical risk for rupture demonstrate increased wall enhancement and thinning on multicontrast 3D vessel wall MRI.

Authors:  Jason Brett Hartman; Hiroko Watase; Jie Sun; Daniel S Hippe; Louis Kim; Michael Levitt; Laligam Sekhar; Niranjan Balu; Thomas Hatsukami; Chun Yuan; Mahmud Mossa-Basha
Journal:  Br J Radiol       Date:  2019-01-30       Impact factor: 3.039

7.  Contrast Enhancement of Intracranial Aneurysms on 3T 3D Black-Blood MRI and Its Relationship to Aneurysm Recurrence following Endovascular Treatment.

Authors:  S Elsheikh; H Urbach; S Meckel
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-13       Impact factor: 3.825

8.  Common Data Elements for Subarachnoid Hemorrhage and Unruptured Intracranial Aneurysms: Recommendations from the Working Group on Subject Characteristics.

Authors:  Philippe Bijlenga; Akio Morita; Nerissa U Ko; J Mocco; Sandrine Morel; Yuichi Murayama; Marieke J H Wermer; Robert D Brown
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

Review 9.  Intracranial Aneurysm: Diagnostic Monitoring, Current Interventional Practices, and Advances.

Authors:  Jason A Ellis; Erez Nossek; Annick Kronenburg; David J Langer; Rafael A Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-10-24

10.  Collagen Turnover in Relation to Risk Factors and Hemodynamics in Human Intracranial Aneurysms.

Authors:  Katharina A M Hackenberg; Hamidreza Rajabzadeh-Oghaz; Rita Dreier; Bruce A Buchholz; Ali Navid; David M Rocke; Amr Abdulazim; Daniel Hänggi; Adnan Siddiqui; R Loch Macdonald; Hui Meng; Nima Etminan
Journal:  Stroke       Date:  2020-03-20       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.